Ubiquitin-Conjugating Enzyme E2E 2 (UBE2E2) (N-Term) Peptide
Quick Overview for Ubiquitin-Conjugating Enzyme E2E 2 (UBE2E2) (N-Term) Peptide (ABIN2185137)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- TEAQRVDDSP STSGGSSDGD QRESVQQEPD REQVQPKKKE GKISSKTAAK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Ube2e2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- UBE2E2 (Ubiquitin-Conjugating Enzyme E2E 2 (UBE2E2))
-
Background
-
Ube2e2 accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro it catalyzes 'Lys-11'- and 'Lys-48'-, as well as 'Lys-63'-linked polyubiquitination.
Alias Symbols: BC016265
Protein Size: 201 -
Molecular Weight
- 22 kDa
-
Gene ID
- 218793
-
NCBI Accession
- NM_144839, NP_659088
-
UniProt
- Q91W82
Target
-